Macau Casino Gambli...
Health Care: Drugs
Alseres Pharmaceuticals Inc. (ALSE: OTC)
$0.12 0.00 | 0.00%
05/31/12 - 01:42 PM ET
Company Profile
| Price and Volume | |
|---|---|
| Recent Price | 0.20 |
| 52 Week High | 0.20 |
| 52 Week Low | 0.20 |
| Avg. Daily Vol. (Mil) | 0.00 |
| Beta (3 year) | -0.50 |
| Share Related Items | |
| Mkt Cap (Mil) | 6.13 |
| Shares Out (Mil) | 30.64 |
| Float (Mil) | 10.29 |
| Dividend Information | |
| Yield % | 0.00 |
| Annual Dividend | 0.00 |
| Payout Ratio | 0.00 |
| Financial Strength | |
| Quick Ratio | 0.00 |
| Current Ratio | 0.00 |
| LT Debt/ Equity | 0.00 |
| Total Debt / Equity | n.a. |
| Valuation Ratios | |
| Price Earnings | n.a. |
| Price/Sales | 24.51 |
| Price/Book | 0.00 |
| Price/Cash Flow | -2.90 |
| Per Share Data | |
| Earnings | -0.08 |
| Sales | 0.01 |
| Book Value | 0.00 |
| Cash Flow | -0.07 |
| Business Summary | |
|---|---|
| Alseres Pharmaceuticals, Inc. is focused on the development of diagnostic and therapeutic products for disorders in the central nervous system. | |
| General Information | |
| 239 South Street
Hopkinton, MA 01748 |
|
| www.alseres.com | |
| Industry : Drugs | |
| Sector: Health Care | |
| Employees: 3 | |
| CEO: Mr. Peter G. Savas | |
| Short Interest | |
| Current Month (Mil) | 0.00 |
| Previous Month (Mil) | 0.00 |
| Short Interest Ratio (Days) | 1.30 |
| Management Effectiveness | |
| Return on Equity | n.a. |
| Return on Assets | -1,015.30 |
| Return on Investments | 6.90 |
| Profitability | |
| Gross Margin | n.a. |
| EBIT Margin | n.a. |
| Profit Margin | 0.00 |
Portfolios with ALSE
- Portfolio NameUser Type
- UserColdKenny Portfolio 1
- Userjoseywales Portfolio 1
Latest ALSE Headlines from TheStreet
Press Releases for ALSE
Partner Headlines for ALSE
